SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-24-000004
Filing Date
2024-02-23
Accepted
2024-02-23 07:08:51
Documents
15
Period of Report
2024-02-19
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K optn-20240219.htm   iXBRL 8-K 26864
5 GRAPHIC optn-20240219_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-24-000004.txt   177411

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20240219.xsd EX-101.SCH 1904
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20240219_lab.xml EX-101.LAB 24851
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20240219_pre.xml EX-101.PRE 13048
16 EXTRACTED XBRL INSTANCE DOCUMENT optn-20240219_htm.xml XML 2528
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 24667222
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)